List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 152 studies with search of: Viral Encephalitis
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine
Condition: Encephalitis, Japanese B
Intervention: Biological: Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine
2 Active, not recruiting Determining Long-Term Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine
Condition: Encephalitis, Japanese B
Intervention: Biological: Live attenuated SA 14-14-2 vaccine
3 Recruiting Prospective Observational Epidemiologic Study of Maraviroc's Safety
Condition: Human Immunodeficiency Virus
Interventions: Drug: Maraviroc along with an optimized background antiretroviral drug regimen;   Drug: Optimized background antiretroviral drug regimen without maraviroc
4 Not yet recruiting Rijavithi Viral PCR Arrays in CNS Infection Study
Condition: CNS Viral Infection
Intervention: Other: LUMBAR PUNCTURE
5 Recruiting Treatment of Japanese Encephalitis
Condition: Japanese Encephalitis
Intervention: Drug: Ribavirin
6 Completed Live Attenuated Japanese Encephalitis (JE) Vaccine Coadministered With Measles Vaccine in Infants 9 Months of Age
Condition: Japanese Encephalitis
Intervention: Biological: Japanese encephalitis live attenuated SA 14-14-2 vaccine
7 Completed Boosterability of Live Attenuated Japanese Encephalitis (JE) Vaccine in Children Who Have Previously Received Inactivated JE Vaccine
Condition: Japanese Encephalitis
Intervention: Biological: Japanese encephalitis live attenuated SA 14-14-2 vaccine
8 Recruiting A Phase II, Open Label Trial of a Vaccine (FSME-IMMUN 0.5 mL Baxter) Against Tick-borne Encephalitis (TBE) for NIAID Workers Manipulating Tick Borne Encephalitis Virus (TBEV) in the Laboratory
Conditions: Tick-Borne Encephalitis;   Encephalitis, Tick-Borne;   Tick-Borne Disease;   Glycoprotein E, Flavivirus;   NSI Protein, Flavivirus
Intervention: Biological: FSME-IMMUN 0.5ml Baxter
9 Enrolling by invitation Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine in Toddlers
Conditions: Encephalitis;   Japanese Encephalitis
Intervention:
10 Withdrawn Safety, Tolerability and Immunogenicity of the Venezuelan Equine Encephalitis (VEE) Attenuated Live-Virus Vaccine
Condition: Venezuelan Equine Encephalitis
Intervention: Biological: VEE 3526
11 Completed Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4-3'delta30) in Healthy Adults
Condition: West Nile Fever Encephalitis
Interventions: Biological: WN/DEN4-3'delta30;   Biological: Placebo
12 Completed Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®)
Conditions: Japanese Encephalitis;   Yellow Fever
Interventions: Biological: Live attenuated Japanese encephalitis virus; Yellow fever virus;   Biological: Yellow fever virus; Live attenuated Japanese encephalitis virus
13 Completed IVIG - West Nile Encephalitis: Safety and Efficacy
Condition: West Nile Virus
Interventions: Drug: Omr-lgG-am;   Drug: Placebo;   Drug: Polygam® S/D
14 Completed Natural History of West Nile Virus Infection
Conditions: West Nile Virus;   Encephalitis;   Myelitis
Intervention:
15 Completed Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults
Condition: Tick-Borne Encephalitis
Interventions: Biological: LGT(TP21)/DEN4;   Biological: Placebo
16 Completed Study of Live Attenuated ChimeriVax™-Japanese Encephalitis Vaccine
Condition: Japanese Encephalitis
Interventions: Biological: Live attenuated Japanese encephalitis virus;   Biological: ChimeriVax™ diluent
17 Recruiting Treatment of West Nile Virus With MGAWN1
Conditions: West Nile Neuroinvasive Disease;   West Nile Virus Infection;   Encephalitis;   Meningitis;   Acute Flaccid Paralysis
Interventions: Biological: MGAWN1;   Biological: Placebo - normal saline
18 Completed Evalution of Immunogenicity, Safety and Booster Response of a Rabies Vaccine Administered Concomitantly With Japanese Encephalitis Vaccine in Toddlers
Conditions: Rabies;   Japanese Encephalitis;   Pre-Exposure Prophylaxis
Interventions: Biological: Three 1 mL doses of Rabies vaccine and two JE vaccine;   Biological: Three 0.5 mL doses of Rabies vaccine and two JE vaccine;   Biological: Three 0.1mL doses of Rabies Vaccine and two JE vaccine;   Biological: Two 0.1mL doses of Rabies vaccine and two JE vaccine;   Biological: Two doses of JE vaccine
19 Completed Omr-IgG-am™ (Trademark) for Treating Patients With or at High Risk for West Nile Virus Disease
Condition: West Nile Virus
Intervention: Drug: Omr-IgG-am
20 Completed Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children
Condition: Encephalitis, Tick-Borne
Intervention: Biological: Formaldehyde inactivated, sucrose gradient purified TBE virus antigen, strain Neudörfl

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services